ARCHIVE

Aurion Biotech to Present Clinical Trial Results at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Efficacy data from Escalón study shows improvements in central corneal thickness and best corrected visual acuity May 2, 2023 – Seattle, Cambridge and Tokyo – Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced several presentations during the 2023 American Society of Cataract and Refractive Surgery (ASCRS)...

March Milestone

By Greg Kunst, CEO  A lot of things seem to happen in March – Caesar’s assassination, Shakespeare’s Ides (a fortune-teller’s warning of the aforementioned assassination), the Spring Equinox, and (of course) March Madness.But Aurion’s most recent March Milestone augurs only good things – especially for the millions of patients around the world who suffer from...

Aurion Biotech Receives Approval from Japan’s PMDA for New Drug Application

First approval in the world forallogeneic cell therapy to treat corneal endothelial disease March 23, 2023 – Seattle, Cambridge MA and Tokyo – Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMD A),...

Jonathan Sparks, JD, PhD Joins Aurion Biotech as Chief Legal Officer

Deep Expertise in Intellectual Property to Support Company’s Innovations  December 7, 2022 – Seattle, Boston and Tokyo – Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has appointed Dr. Jonathan Sparks as chief legal officer. Dr. Sparks will lead the company’s global legal...

Aurion Biotech Expands Its Leadership Team

Regulatory Affairs and Clinical Operations Vice Presidents Add Key Expertise as Company Prepares to Initiate U.S. Clinical Trials November 30, 2022 – Seattle, Boston and Tokyo – Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has appointed Sherita Hall as vice president, clinical operations...

Aurion Biotech Wins Prestigious Prix Galien Startup Award

Company recognized for innovations in clinically validated cell therapy for corneal endothelial dystrophiesOctober 27, 2022 – Seattle, Boston and Tokyo – Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has won the prestigious Prix Galien Award for Best Startup in Biotech / Pharma....

Living Our Values at Aurion Biotech

As others have said both are valid and will do the trick. I'm not 100% convinced that they are identical though. If you have some style cascading going on then they could in theory produce different results since they are effectively override.

A Culture of Curiosity and Collaboration

As others have said both are valid and will do the trick. I'm not 100% convinced that they are identical though. If you have some style cascading going on then they could in theory produce different results since they are effectively override.

Summer Solstice or Mid-year Madness? 

As others have said both are valid and will do the trick. I'm not 100% convinced that they are identical though. If you have some style cascading going on then they could in theory produce different results since they are effectively override.

Aurion Biotech Appoints Dr. Michael Goldstein as President and Chief Medical Officer

As others have said both are valid and will do the trick. I'm not 100% convinced that they are identical though. If you have some style cascading going on then they could in theory produce different results since they are effectively override.